Skip to main content

INVESTING IN INNOVATION

Commercialising world class research from UCL

£0M

HAS been invested in UCL projects

0

Proof of concept investments

0

PORTFOLIO COMPANIES

0

Licensing projects

Why you should consider manufacturing from the start of the biotech R&D process

NovalGen doses first patient in Phase I study in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma

UCL, Imperial College London and University of Cambridge are behind innovative industry university collaboration receiving £100m funding to rapidly advance cutting-edge science

Achilles Therapeutics Announces Pricing of Initial Public Offering

UCL Technology Fund secures partnership with Viralgen, leading gene therapy manufacturer

Intrinsic closes £1.35m seed funding round to prototype next generation memory devices